Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product, aram... Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product, aramchol, is a disease-modifying treatment for fatty liver disorders, including Non-Alcoholic Steato-hepatitis. Aramchol affects liver fat metabolism and has been shown in a Phase IIa clinical study to reduce liver fat content, as well as improve metabolic parameters associated with Nonalcoholic steatohepatitis. Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.01 | -0.34965034965 | 2.86 | 3.04 | 2.8134 | 22051 | 2.91201064 | CS |
| 4 | -0.17 | -5.62913907285 | 3.02 | 3.61 | 2.79 | 32991 | 3.05016412 | CS |
| 12 | -0.34 | -10.65830721 | 3.19 | 3.61 | 2.56 | 44104 | 2.99565106 | CS |
| 26 | -0.87 | -23.3870967742 | 3.72 | 23.8 | 2.56 | 1547014 | 11.21989174 | CS |
| 52 | -1.692 | -37.2523117569 | 4.542 | 23.8 | 2.56 | 841032 | 10.65872238 | CS |
| 156 | -272.55 | -98.9651416122 | 275.4 | 330.858 | 2.56 | 374060 | 24.70355404 | CS |
| 260 | -1012.35 | -99.7192671395 | 1015.2 | 1158.804 | 2.56 | 296863 | 180.11961864 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
